Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients.
Sanfang TuLijuan ZhouRui HuangXuan ZhouJilong YangYanjie HeYuxing HuHonghao ZhangXiaoling XieYu-Hua LiPublished in: American journal of hematology (2024)